On April 11, the Senate passed the Stem Cell Research Enhancement Act (S.5) by a vote of 63-34. President Bush has threatened to veto this bill, which is nearly identical to the legislation that passed the House and Senate in the previous Congress. Federal funding for human embryonic stem cell research is allowed only for research using embryonic stem cell lines created on or before Aug. 9, 2001, under a policy announced by Bush on that date.
S. 5 and the House-passed version, HR.3, would allow federal funding for research using stem cells derived from human embryos originally created for fertility treatments and willingly donated by patients. The Senate measure differs from a House-approved bill because it includes language that would require NIH to research and fund methods of creating embryonic stem cell lines without destroying embryos
Over 200 AAN members responded to the Academy's action alert on the S. 5 vote by emailing their Senators in support of this legislation, which is consistent with the AAN's position on stem-cell research. The AAN has also been working collaboratively as a member of the Coalition for the Advancement of Medical Research to advance this issue. CAMR is the largest advocacy organization in America in favor of improving stem-cell research opportunities.